Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current issues in non-inferiority trials.

Thomas R Fleming1

  • 1Department of Biostatistics, University of Washington, Seattle, WA 98195, USA. tfleming@u.washington.edu

Statistics in Medicine
|March 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Select Contemporary Statistical Concepts in Heart Failure Clinical Trials: Insights From the Heart Failure Collaboratory.

JACC. Heart failure·2026
Same author

Rejoinder to Commentaries on "A Perspective on the Appropriate Implementation of ICH E9(R1) Addendum Strategies for Handling Intercurrent Events".

Statistics in medicine·2026
Same author

Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association.

Circulation·2026
Same author

Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Clinical trials for continuously monitored and updated AI systems.

Nature medicine·2026
Same author

Reflections on FDA Draft Guidance on Bayesian Methods in Trials-Protecting Scientific Integrity and Evidentiary Standards.

JAMA·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Non-inferiority (NI) trials compare new interventions against standard care. These trials require careful design and high-quality conduct to reliably assess efficacy and manage risks effectively.

Area of Science:

  • Clinical Trials Methodology
  • Regulatory Science
  • Evidence-Based Medicine

Background:

  • Non-inferiority (NI) trials directly compare experimental interventions with standard care, assessing relative benefit-to-risk profiles.
  • Their utility is maximized when standard care efficacy is well-established and relevant to the NI trial setting.
  • Significant uncertainties persist regarding optimal NI trial design, conduct standards, and result interpretation in clinical practice.

Purpose of the Study:

  • To provide insights into the application of non-inferiority trials for evaluating new interventions.
  • To address challenges and uncertainties in the design, conduct, and interpretation of NI trials.
  • To examine specific aspects like 'imputed placebo' and 'margin'-based designs, and the risk of 'bio-creep'.

Main Methods:

Related Experiment Videos

  • Review and consideration of recent non-inferiority trial examples.
  • Discussion of design approaches including 'imputed placebo' and 'margin'-based methods.
  • Analysis of challenges such as 'bio-creep', safety risk assessment, and quality standards.

Main Results:

  • Recent examples highlight persistent challenges in the effective use of NI trials.
  • The risk of 'bio-creep' with repeated NI trials and the application of NI for safety risk assessment are discussed.
  • Higher standards for study conduct quality are necessary for NI trials, debunking the myth of always requiring huge sample sizes.

Conclusions:

  • Non-inferiority trials are valuable tools for assessing new interventions when designed and conducted rigorously.
  • Addressing uncertainties in design, conduct, and interpretation is crucial for reliable evaluation.
  • Careful consideration of potential pitfalls like 'bio-creep' and appropriate quality standards are essential for valid results.